The Lifetime Review Of265NSCLC Patients Treated By Traditional Chinese Medicine

Objective:The retrospective analysis of lifetime was employed to study the265patients with non-small cell lung cancer who recived treatment in Oncology Department during January2001to January2010, and in order to understand the characteristics of primary lung cancer, relationships between the diagnosis and treatment and lifetime of primary lung cancer, which may contribute to finding more effective treatment methods, improving the quality of life and extending the lifetime.The effectiveness and scientificalness of combination of traditional Chinese medicine and modern medicine on treating non-small cell lung cancer was explored so as to provide some new thoughts and methods for the treatment of non-small cell lung cancer.Methods:The gender, age, smoking history, classification of TCM syndromes, clinical stages and different treatment methods were described among the265patients with non-small cell lung cancer.The k-m method was adopted to analyze the lifetime, and the lifetime presented as median survival time and mean survival time.And the survival rate of six month,one year,three years and five years were evaluated and elaborate into survival function.The relevant factors,having a impact on the lifetime,was analyzed with statistics.Results:1、The265NSCLC patients with a male to female ratio was2.15:1, and the age of onset is usually over40years old.Moreover/with the rise of the age,the higher the incidence rate of the disease. The average age of onset was61.42.2、The syndrome of qi deficiency and phlegm and dampness was the main pattern for the265NSCLC patients, with excess syndromes in the early stage,complex of excess and deficiency in the middle stage and deficiency syndrome in the late stag.And the classification of TCM syndromes could impact the survival period and survival rate.The NSCLC patients with a smoking history has a shorter lifetime than those without a smoking history. The NSCLC patients who received the treatment of combination of traditional chinese medicine and modern medicine could improve the quality of life and extend the lifetime.3、The mean survival time of the265patients was30.25months.The median survival time was26months,and the survival rate of median survival time were96.98%(6months),81.13%(12months),33.96%(3years) and13.21%(five years) respectively.The mean survival time of Stage I non-small cell lung cancer patients was65.46months,with the median survival time of64months,and the mean survival rate100%(6months),100%(12months),90.91%(3years) and63.64%(five years) respectively. The mean survival time of Stage Ⅱ non-small cell lung cancer patients was53.68months, with the median survival time of53months,and the mean survival rate100%(6months),100%(12months),90.18%(3years) and38.24%(five years) respectively.The mean survival time of Stage Ⅲ non-small cell lung cancer patients was27.79months, with the median survival time of25months.and the mean survival rate96.55%(6months),84.48%(12months),27.58%(3years) and7.76%(five years) respectively. Meanwhile,the mean survival time of Stage IV non-small cell lung cancer patients was21.62months, with the median survival time of19months,and the mean survival rate96.15%(6months),70.19%(12months),14.42%(3years) and4.81%(five years) respectively.Conclusion:The combination of traditional Chinese medicine and modern medicine in treating non-small cell lung cancer can prolong the survival time of the patients, and it is worth to be promoted and developed.